Submitted by Christine Alexander on Thu, 03/10/2013 - 16:23
Damian Crowther and colleagues have won the 2013 Carpe Diem Life Science Award for the best startup company, in the University of Cambridge's Entrepreneurs Business Creation Competition.
Their company, Floceleris, is developing a pre-symptomatic test to capture and measure the seeded aggregation of amlydoid beta peptides from clinical samples. The test will be used to find new drugs that inhibit disease progression and serve as a companion diagnostics tool to stratify patients and personalize treatments for Alzheimer's patients.
More details on the Floceleris website - www.floceleris.com)